Stefan Wolking

Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death.

M. Weller, W. Wick, J. Steinbach, 2009, Brain : a journal of neurology.